breast cancer glp 1 GLP-1 use linked to lower incidence Exendin-4 and GLP-1 inhibit breast

It is a dietary supplement, not a medication, and has not been reviewed by the FDA for safety or effectiveness

Drug-induced acute pancreatitis in a cohort of 328 patients

The peptide appears to act through direct interaction with adipocytes (fat cells), potentially involving activation of hormone-sensitive lipase (HSL) and modulation of -adrenergic receptor signaling pathways

As described already, glucotoxicity, endothelial damage by inflammation, oxidative stress and cytokine production contribute to an increased risk of thromboembolic complications and of damage to vital organs in patients with diabetes mellitus 60 (Fig